Palliative Care

Publication Title: 
Oncology (Williston Park, N.Y.)

Xerostomia is a permanent and devastating sequela of head and neck irradiation, and its consequences are numerous. Pharmaceutical therapy attempts to preserve or salvage salivary gland function through systemic administration of various protective compounds, most commonly amifostine (Ethyol) or pilocarpine. When these agents are ineffective or the side effects too bothersome, patients often resort to palliative care, for example, with tap water, saline, bicarbonate solutions, mouthwashes, or saliva substitutes.

Author(s): 
Kahn, Shannon T.
Johnstone, Peter A. S.
Publication Title: 
BMJ (Clinical research ed.)
Author(s): 
Colvin, Lesley
Forbes, Karen
Fallon, Marie
Publication Title: 
Aǧrı: Ağrı (Algoloji) Derneği'nin Yayın Organıdır = The Journal of the Turkish Society of Algology

The use of complementary and alternative medicine (CAM) has grown in popularity both among the general population and among the cancer patients. Cancer patients often use CAM, which is a treatment that is not commonly used in the conventional setting. However, the prevalence of CAM use appears to vary substantially, with reported frequency of use of at least one CAM therapy ranging from 20% to 83.3%. Complementary medicine has become an important aspect of palliative cancer care.

Author(s): 
Yildirim, Yasemin Kuzeyli
Fadiloğlu, Ciçek
Uyar, Meltem
Publication Title: 
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology

PURPOSE: Dyspnea is one of the most distressing symptoms experienced by terminally ill cancer patients. This study aimed to evaluate the role of interventions for the palliation of dyspnea. METHODS: We conducted a systematic review of randomized controlled trials assessing all pharmacologic and nonpharmacologic interventions for dyspnea palliation in cancer patients, and searched the Cochrane Library, MEDLINE, conference proceedings, and references. Two reviewers independently appraised the quality of trials and extracted data. RESULTS: Our search yielded 18 trials.

Author(s): 
Ben-Aharon, Irit
Gafter-Gvili, Anat
Paul, Mical
Leibovici, Leonard
Stemmer, Salomon M.
Publication Title: 
Hematology/Oncology Clinics of North America

Clinical research on acupuncture in cancer care is a new and challenging field in oncology. The results of clinical research will continue to provide clinically relevant answers for patients and oncologists. The evidence currently available has suggested that acupuncture is a safe and effective therapy to manage cancer and treatment related symptoms, while giving patients the ability to actively participate in their own care plan. The article explains the potential benefits of acupuncture and describes the difficulties in studying its effectiveness.

Author(s): 
Lu, Weidong
Dean-Clower, Elizabeth
Doherty-Gilman, Anne
Rosenthal, David S.
Publication Title: 
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Evidence for integrative therapies (IT) in children with hematological malignancies is slowly evolving. The ideal model of integrative pediatric oncology would offer IT modalities that are deemed safe and effective in conjunction with effective conventional medical treatments. Because of potential interactions, herbs and other dietary supplements should be used with caution, especially during active therapy. Health and wellness should be the emphasis, with IT therapies supporting health promotion and key disease prevention strategies for childhood cancer survivors.

Author(s): 
Kelly, Kara M.
Publication Title: 
Journal of Palliative Medicine

Although dyspnea is frequently encountered in the palliative care setting, its optimal management remains uncertain. Clinical approaches begin with accurate assessment, as delineated in part one of this two-part series. Comprehensive dyspnea assessment, which encompasses the physical, emotional, social, and spiritual aspects of this complex symptom, guide the clinician in choosing therapeutic approaches herein presented as part two.

Author(s): 
Kamal, Arif H.
Maguire, Jennifer M.
Wheeler, Jane L.
Currow, David C.
Abernethy, Amy P.
Publication Title: 
The Oncologist

Optimal oncologic care of older men with prostate cancer, including effective prevention and management of the disease and treatment side effects (so-called best supportive care measures) can prolong survival, improve quality of life, and reduce depressive symptoms. In addition, the proportion of treatment discontinuations can be reduced through early reporting and management of side effects. Pharmacologic care may be offered to manage the side effects of androgen-deprivation therapy and chemotherapy, which may include hot flashes, febrile neutropenia, fatigue, and diarrhea.

Author(s): 
Scotté, Florian

Pages

Subscribe to RSS - Palliative Care